Select a Cancer Type:
Myeloma
Myeloma
RELATED ARTICLES
Living With the Unknown: Jonathan Gluck on Multiple Myeloma and Learning to Navigate Uncertainty
March 31, 2026
Author and multiple myeloma survivor Jonathan Gluck shares how an unexpected diagnosis reshaped his identity and approach to living with uncertainty.
Breaking Down Bispecific Antibodies and Their Shift to Earlier Lines of Treatment
March 17, 2026
Dr. Joseph Mikhael, chief medical officer of the International Myeloma Foundation, provided updates from the front lines of treatment advancement.
.jpg?fit=crop&auto=format)
Mezigdomide Combo Delays Progression in Multiple Myeloma Phase 3 Trial
March 09, 2026
The SUCCESSOR-2 study shows MeziKd improves progression-free survival for relapsed multiple myeloma patients previously treated with anti-CD38 drugs.
.jpg?fit=crop&auto=format)
Multiple Myeloma Clinical Trial Led to More Than Four Years of Remission
March 04, 2026
Survivor Julie Cohen discusses her experience with cevostamab, managing CRS side effects, and reaching MRD-negative status through a clinical trial.
Expert Discusses the Impact of Longer Survival After Cancer Diagnosis
February 18, 2026
ACS data show rising five-year survival and shifting cancer care toward survivorship, access to novel therapies and prevention as incidence climbs.
Myeloma Survivor Shares “Justifiable Hope” After 8-Year Remission
February 18, 2026
A myeloma survivor in long remission shares how research, expert care and advocacy turned fear into hope as more patients live longer after cancer
Advertisement
Advertisement